Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence
about
A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responsesSubversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapseOrthopoxvirus genes that mediate disease virulence and host tropismHepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasionVaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell linesEvasion of antiviral immunity through sequestering of TBK1/IKKε/IRF3 into viral inclusion bodiesInhibition of IkappaB kinase by vaccinia virus virulence factor B14Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activationVaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7Innate immune recognition of viral infectionCommensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injuryPathogen recognition and inflammatory signaling in innate immune defensesInterferon induction by RNA viruses and antagonism by viral pathogensIntracellular nucleic acid sensors and autoimmunityToll-like receptors in antiviral innate immunityDeletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-CTranslational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunityToll-like receptors regulation of viral infection and disease☆West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal TransductionToll-Like Receptors and Viruses: Induction of Innate Antiviral Immune ResponsesMutations in Classical Swine Fever Virus NS4B Affect Virulence in SwineVaccinia Virus Proteins A52 and B14 Share a Bcl-2–Like Fold but Have Evolved to Inhibit NF-κB rather than ApoptosisMechanism of Bacterial Interference with TLR4 Signaling by Brucella Toll/Interleukin-1 Receptor Domain-containing Protein TcpBCharacterization and Structure of the Vaccinia Virus NF-κB Antagonist A46The Brucella TIR-like protein TcpB interacts with the death domain of MyD88IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitinationSubversion of innate immune signaling through molecular mimicryModulation of NF-κB signalling by microbial pathogensVaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein familyGenome of crocodilepox virus.Host-pathogen interactions: a biological rendez-vous of the infectious nonself and danger models?Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).Protective effect of Toll-like receptor 4 in pulmonary vaccinia infectionThe poxvirus A35 protein is an immunoregulatorDifferential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses.A novel inhibitor of the NF-{kappa}B signaling pathway encoded by the parapoxvirus orf virusStructure of vaccinia virus A46, an inhibitor of TLR4 signaling pathway, shows the conformation of VIPER motif.Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.The shrimp NF-κB pathway is activated by white spot syndrome virus (WSSV) 449 to facilitate the expression of WSSV069 (ie1), WSSV303 and WSSV371.
P2860
Q21135240-EC0BE82C-71D0-48DF-B513-ABF146AF48BAQ21144516-785BD1D1-470C-4AC1-9999-DC860094B8B4Q21285044-7894A38C-51AD-45C7-B45A-053AF1FC94DFQ24293039-F6FFF367-4F7A-4342-A611-E6C60DB95BCFQ24306761-3812B300-5350-42A8-951B-C49ACDCAEC6CQ24310415-88A98F06-9454-4AC9-A224-302FF59B41E0Q24312835-37FD385A-F777-4EBB-ACAD-CCD0C4B1F0FBQ24312867-F2304D8C-CC36-4F7F-A807-211775A844F0Q24315019-2CF8C528-8A94-4749-A657-CC9C2ED821A1Q24338222-7340AA15-05F6-4CFC-96DB-4D38000C57E1Q24498364-06B733B5-C651-45CC-A348-2206E7DCEE55Q24600221-E797D45E-6352-4FE9-B713-86937F91D261Q24643034-26A4EA8E-21DF-447B-AF5D-C45C2E295580Q26860007-17CC4DA7-6E79-4FF8-9952-B5801BEC8F4BQ26997316-140389C0-99BA-4771-81B4-B9A1A66BC4F6Q27011462-32EE556C-FDEB-47EB-826A-BDFDEB29A795Q27306437-F1C4CBCD-DC3A-40AB-9B43-F3CEDC219D1EQ27478142-F51CD996-6F8C-418E-A28C-1512392A372DQ27486231-A3B02450-D3D7-4EA6-AA15-B8886F743E55Q27486783-EE106DF1-A09E-462D-A17F-C87F4EA29DDFQ27487393-6C37A198-1C32-40FC-9C0F-DD137A0B4F2EQ27490847-CFBFAD61-3BB0-4091-93AB-6711D211387BQ27651621-8066C7BA-46E2-45B2-A5F4-A7D5BAD3D47CQ27680670-DDB81F21-C002-45F4-BEB5-DFEFCD704A3AQ27680981-3C77A07B-659F-4B17-AA57-A32A067D2C2DQ28119112-EB1F0511-F46B-4D0A-B4B8-123124DE5FE1Q28249343-75B3C752-420F-4F03-83F6-9F4332F03800Q28383667-633E968A-07BF-418B-9877-66FDD695DE95Q28709497-FE2395CC-AD5F-41FE-AED0-9827FC7E6CA0Q30370948-97CC217E-F11E-4A10-AB83-A372FDCE5F06Q33241222-D05F5595-235C-480C-A58C-CE68F5E24CB0Q33245068-6E3C789C-2E85-41E1-B7E2-5848AAF15812Q33320536-9E174470-4809-498C-9244-E02B205D5855Q33370547-1705BB88-B057-4E96-82A7-77515BB0E407Q33558734-AC9A2915-9667-4D99-B8B2-EEC74125707DQ33602820-F8495343-21E9-4B9B-8629-B5A670C48F06Q33769300-692768EC-3127-40FB-A31D-F5C158C027AFQ33870595-B33E1F42-5EEA-4889-88D7-08042C03128EQ33910501-D6532A56-2F2E-4795-9B25-9974A3F91C10Q34024034-845725E6-A93F-4EF6-AB68-0CE1C7F9B866
P2860
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Vaccinia virus protein A46R ta ...... s and contributes to virulence
@ast
Vaccinia virus protein A46R ta ...... s and contributes to virulence
@en
type
label
Vaccinia virus protein A46R ta ...... s and contributes to virulence
@ast
Vaccinia virus protein A46R ta ...... s and contributes to virulence
@en
prefLabel
Vaccinia virus protein A46R ta ...... s and contributes to virulence
@ast
Vaccinia virus protein A46R ta ...... s and contributes to virulence
@en
P2093
P2860
P50
P356
P1476
Vaccinia virus protein A46R ta ...... s and contributes to virulence
@en
P2093
Geoffrey L Smith
Geraldine Maloney
Ismar R Haga
Julianne Stack
Katherine A Fitzgerald
Martina Schröder
P2860
P304
P356
10.1084/JEM.20041442
P407
P577
2005-03-14T00:00:00Z